Author Bio
Eric has been writing about stocks and finance since the mid-1990s, when he lived in Prague, Czech Republic. Over the course of a varied career, he has also been a radio newscaster, an investment banker, and a bass player in a selection of rock and roll bands. A native New Yorker, he currently lives in Los Angeles.
Investors might be high on marijuana stocks these days, but a notable analyst isn't exactly bullish on one of the top names in the sector.
On Friday, Piper Sandler's Michael Lavery cut his recommendation on industry bellwether
Canopy Growth (NASDAQ:CGC) from overweight to neutral. He is maintaining his price target of $27 per share, meaning that he believes the stock could fall by nearly 40% from its current level.